Navigation Links
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
Date:1/30/2008

Vivian Cheung, M.D., a pediatric neurologist at The Childrens Hospital of Philadelphia and the University of Pennsylvania School of Medicine, has been named a Howard Hughes Medical Institute (HHMI) investigator. Following a nationwide competition in 2007, Cheung was one of 15 physician-scientists selected recently by the prestigious research organization.

Like all those chosen, Dr. Cheung focuses on translating research discoveries into improved medical treatments.

We are extremely pleased and proud of the fact that one of our pediatricians was honored by one of the worlds leading biomedical research institutions, said Philip R. Johnson, M.D., chief scientific officer and senior vice president of Children's Hospital. This appointment recognizes Dr. Cheungs accomplishments in advancing genetic discovery.

Cheung investigates how the sequence of DNA units in a persons chromosomes affects that persons susceptibility to disease. She uses microarray technology to rapidly measure how strongly genes are expressed within cells. By determining how gene expression changes in response to drugs and other treatments, she discovers how each patients DNA variations are associated with the effectiveness of their disease treatments.

Her goal is to help physicians predict how a patient will respond to a given drug or treatment, based on the patients particular genetic profile. Ultimately, providing refined genetic tools may remove some of the guesswork in making treatment decisions and in providing the best preventive and therapeutic care.

Trained in neurology, Cheung has a specific interest in a neurogenetic disease called ataxia telangiectasia, which affects movement, muscle control, the immune system and susceptibility to cancer. Because different children may react very differently to their treatments, her research aims to customize treatment to a patients genetic profile, thus minimizing side effects and providing maximum benefits. Cheungs studies could be applied to a broad range of common and uncommon diseases, in using genetic tools to eventually routinely guide physicians and patients to better treatments.

As a pediatrician at Childrens Hospital, Cheung is continuing to work at the Hospital and has become an employee of HHMI, which provides a research budget and funding for laboratory space. Cheung remains an associate professor of Pediatrics and Genetics at the University of Pennsylvania School of Medicine.

After earning her M.D. degree from Tufts University School of Medicine, Cheung completed her residency at the UCLA Medical Center, before coming to The Childrens Hospital of Philadelphia in 1996. She holds the William Wikoff Smith Endowed Chair in Pediatric Genomic Research at Childrens Hospital, where she leads an NIH-funded laboratory.


'/>"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Related medicine news :

1. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
2. Genetics May Determine Antidepressants Effectiveness
3. Genetics Influence Blood Pressure Medications
4. People with anorexia less likely to be blamed when biology, genetics explained
5. Top10 research advances include studies on genetics and stem cell research, stents
6. Heart attack risk from smoking due to genetics
7. Genetics May Boost Mexican-Americans Risk for Alcoholism
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
9. Researchers develop powerful tool to study the genetics of inflammation
10. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
11. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics researcher at Children's Hospital selected as Howard Hughes Medical Institute Investigator
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: